Tools to Improve Medication Continuity in Adolescents With ADHD
Condition: Attention Deficit Hyperactivity Disorder
MeSH terms: Attention Deficit Disorder with Hyperactivity
Study type: Interventional

Summary: 
      Medication is an efficacious treatment strategy for adolescents with
      attention-deficit/hyperactivity disorder (ADHD), however use significantly declines during
      adolescence when the consequences of ADHD are most severe (e.g. dropping out of school,
      delinquency, etc.). The Unified Theory of Behavior Change (UTBC) has been proposed as a
      conceptual model to explain the mechanism underlying ADHD medication adherence and to guide
      the development of interventions to improve the continuity of treatment. The UTBC is a
      well-established and empirically tested model that identifies factors that influence an
      individual's intention to perform a behavior as well as factors that influence whether a
      behavior is actually carried out. Indeed, the research team's preliminary data support the
      relevance of pre-intention factors and implementation factors for medication continuity among
      adolescents with ADHD. Currently, no evidence-based interventions target medication
      continuity for adolescents with ADHD. The objective of this study is to test a
      multi-component intervention that systematically identifies and targets aspects of the UTBC
      model most relevant for each adolescent with poor ADHD medication continuity. The central
      hypothesis is that the tailored intervention will support ADHD medication continuity. The
      study will conduct an open label trial among adolescents with poor medication continuity to
      test whether the intervention engages the mechanism underlying medication continuity and
      improves outcomes.
    


Intervention name(s): Mehealth for ADHD software with medication continuity tools; Mehealth for ADHD software without medication continuity tools
Intervention type(s): Other; Other
Intervention description(s): Medication continuity tools integrated within the mehealth for ADHD software will assess factors influencing medication continuity for each adolescent and recommends tools to address relevant factors. Tools include 1) a system to track outcomes and resolve uncertainty about the need for and/or benefit from medicine, 2) a module to address stigma, 3) a module to help manage side effects, and 4) reminders to take medicine and/or request refills.; The mehealth for ADHD software has multiple functionalities including 1) online training regarding the American Academy of Pediatrics (AAP) ADHD guidelines; 2) an ADHD workflow wizard that guides pediatricians through the creation of an efficient office workflow to deliver quality ADHD care; 3) online collection of parent- and teacher-report ADHD rating scales for the assessment of ADHD as well as monitoring response to medication treatment; 4) integrated algorithms that automatically score rating scales in real time and provide pediatricians with assessment and treatment reports as well as immediate warnings; 5) a communication feature that allows parents, teachers, and pediatricians to communicate with each other; 6) an online pediatrician "report card"; and 7) a Plan-Do-Study-Act wizard that allows pediatricians to select a practice behavior to improve based on their report card and guides them through the creation of small tests of change to improve their office systems.
Intervention model: Single Group Assignment
Intervention model description: Open Label Trial
Masking: None (Open Label)
Primary purpose: Health Services Research